A Multicenter,Randomized,Double-Blind , Placebo -controlled phase 3 study to evaluate the efficacy and safety of Baricitinib in adult patients with moderate to severe : A topic dermatitis

Ítems similars

• A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BARICITINIB IN ADULT PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
  per: Sakshi Shrirang Shinde
  Publicat: (2025)
• A Multicenter, Randomized, Double -Blind , Placebo-controlled Phase 3 Study to evaluate the efficacy and safety of Baricitinib in Adult Patients with Moderate to Severe a topic Dermatitis
  per: Sharanya Shettigar
• A Multicenter,Randomized, Double-Blind, Placebo-controlled Phase 3 study to evaluate the efficacy and safety of Baricitinib in adult patients with moderate to severe a topic Dermatitis
  per: Aman Dwivedi
• Blind faith
  per: Ghose, Sagarika
  Publicat: (2006)
• Blind faith
  per: Ghose, Sagarika
  Publicat: (2006)